Finland's jointly prepared medicines policy is 'an excellent start,' says trade group PIF, which names new board

Last year’s most important effort for the entire pharmaceutical industry in Finland, the reform of the national medicines policy, has now been finalized. The Ministry of Social Affairs and Health prepared the medicines policy in close co-operation with the drug trade body Pharma Industry Finland (PIF), which said it was extremely pleased with the joint preparation.

“The outlines drawn for the pharmaceutical service constitute an obligation to take better notice of the needs of the health care system and society. PIF must face this challenge together with its member companies," says Suvi-Anne Siimes, general manager of PIF.

The new Medicine Policy defines the priorities to tackle and the ways to get there. The most important work lies ahead: the objectives must be turned into concrete pharmaceutical legislation and operative models.